JP2024516003A5 - - Google Patents
Info
- Publication number
- JP2024516003A5 JP2024516003A5 JP2023566803A JP2023566803A JP2024516003A5 JP 2024516003 A5 JP2024516003 A5 JP 2024516003A5 JP 2023566803 A JP2023566803 A JP 2023566803A JP 2023566803 A JP2023566803 A JP 2023566803A JP 2024516003 A5 JP2024516003 A5 JP 2024516003A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- therapeutic agent
- composition according
- patient
- diabetic retinopathy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163182037P | 2021-04-30 | 2021-04-30 | |
| US63/182,037 | 2021-04-30 | ||
| PCT/US2022/027062 WO2022232597A1 (en) | 2021-04-30 | 2022-04-29 | Methods and compositions for treatment of diabetic retinopathy and related conditions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024516003A JP2024516003A (ja) | 2024-04-11 |
| JP2024516003A5 true JP2024516003A5 (enExample) | 2025-05-09 |
Family
ID=83848745
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023566803A Pending JP2024516003A (ja) | 2021-04-30 | 2022-04-29 | 糖尿病網膜症および関連する状態を治療するための方法および組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240216315A1 (enExample) |
| EP (1) | EP4329741A4 (enExample) |
| JP (1) | JP2024516003A (enExample) |
| KR (1) | KR20240049212A (enExample) |
| CN (1) | CN117500492A (enExample) |
| AU (1) | AU2022264037A1 (enExample) |
| BR (1) | BR112023022561A2 (enExample) |
| CA (1) | CA3217136A1 (enExample) |
| IL (1) | IL308083A (enExample) |
| MX (1) | MX2023012793A (enExample) |
| WO (1) | WO2022232597A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4587003A2 (en) | 2022-09-14 | 2025-07-23 | Opus Genetics, Inc. | Salts and esters of apx3330 and therapeutic uses thereof |
| WO2024158972A1 (en) * | 2023-01-25 | 2024-08-02 | Ocuphire Pharma, Inc. | Methods and compositions for preventing the progression of diabetic retinopathy and related conditions |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2008304619C1 (en) * | 2007-09-26 | 2020-06-04 | Indiana University Research And Technology Corporation | Benzoquinone derivative E3330 in combination with chemotherapeutic agents for the treatment of cancer and angiogenesis |
| AU2019218797B2 (en) * | 2018-02-08 | 2023-09-21 | Indiana University Research And Technology Corporation | Targeting ocular diseases with novel APE1/Ref-1 inhibitors |
-
2022
- 2022-04-29 AU AU2022264037A patent/AU2022264037A1/en active Pending
- 2022-04-29 BR BR112023022561A patent/BR112023022561A2/pt unknown
- 2022-04-29 EP EP22796862.5A patent/EP4329741A4/en active Pending
- 2022-04-29 JP JP2023566803A patent/JP2024516003A/ja active Pending
- 2022-04-29 KR KR1020237041163A patent/KR20240049212A/ko active Pending
- 2022-04-29 CA CA3217136A patent/CA3217136A1/en active Pending
- 2022-04-29 US US18/288,435 patent/US20240216315A1/en active Pending
- 2022-04-29 MX MX2023012793A patent/MX2023012793A/es unknown
- 2022-04-29 IL IL308083A patent/IL308083A/en unknown
- 2022-04-29 WO PCT/US2022/027062 patent/WO2022232597A1/en not_active Ceased
- 2022-04-29 CN CN202280038694.0A patent/CN117500492A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025169389A5 (enExample) | ||
| TWI250016B (en) | Use of pramipexole for the treatment of addictive disorders | |
| JP5212849B2 (ja) | 眼内血管新生及び／又は眼内血管透過性亢進を伴う疾患の予防又は治療のための医薬 | |
| JP6353577B2 (ja) | 組み合わせ組成物 | |
| EP3856478A1 (en) | Formulations for treatment of dry eye disease | |
| JPH0222229A (ja) | 神経細胞及び神経繊維の疾患もしくは傷害の治療に用いる組み合わせ調合剤 | |
| JP5897592B2 (ja) | 葉酸−ラミプリルの組合せ：細胞保護性、神経保護性、および網膜保護性の眼科用組成物 | |
| JP2024516003A5 (enExample) | ||
| JP2023154024A (ja) | 眼病態を治療するための方法および組成物 | |
| JP2022533968A5 (enExample) | ||
| Ishibashi | Oral ketoconazole therapy for keratomycosis | |
| EP4520394A3 (en) | New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases | |
| WO2025076151A1 (en) | N-n-dimethyltryptamine (dmt) and dmt analog oral transmucosal film compositions, methods of making, and methods of use thereof | |
| JP2023548429A5 (enExample) | ||
| RU2006124557A (ru) | Композиции и способы введения средств, связывающих тубулин, для лечения глазных заболеваний | |
| JP2015523986A5 (enExample) | ||
| JP2019507786A5 (enExample) | ||
| CZ181193A3 (en) | Pharmaceutical preparation in the form of a solution for local administration in eye, the use and preparation method thereof | |
| JP2004091473A (ja) | 色素沈着改善治療薬 | |
| WO2010117077A1 (ja) | シロリムス誘導体を有効成分として含有する網脈絡膜疾患の治療剤 | |
| JP2021138710A5 (enExample) | ||
| Noguchi et al. | Case report. Sporotrichosis successfully treated with itraconazole in Japan | |
| SCHEIE et al. | Treatment of herpes zoster ophthalmicus with cortisone or corticotropin | |
| US20190224208A1 (en) | Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation | |
| JP2024545496A5 (enExample) |